XERS · Xeris Biopharma Holdings, Inc.

$8.52 +0.08 (+0.89%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.52B

182.32M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Shannon	Chief Executive Officer	$742,334	—	$2,848,000	$838,615	$607,971	$5,664	$5,042,584
Kevin McCulloch	President and Chief Operating Officer	$543,833	—	$658,600	$698,846	$342,615	$27,079	$2,270,973
Anh Nguyen	Chief Medical Officer	$409,231	—	$1,128,000	$218,945	$232,034	$12,438	$2,000,648
Beth P. Hecht	Chief Legal Officer and Corporate Secretary	$517,089	—	$658,600	$419,307	$293,190	$7,088	$1,895,274
Steven M. Pieper	Chief Financial Officer	$505,393	—	$658,600	$419,307	$286,558	$4,232	$1,874,090

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Edick	Former Chief Executive Officer	$421,449	—	$3,690,000	$538,969	$301,123	$1,875,067	$6,826,608
John Shannon	Chief Executive Officer	$629,193	—	$2,452,500	$309,037	$433,475	$2,904	$3,827,109
Beth P. Hecht	Chief Legal Officer and Corporate Secretary	$491,732	—	$1,845,000	—	$267,748	$8,345	$2,612,825
Kevin McCulloch	President and Chief Operating Officer	$490,349	—	$1,594,500	$206,024	$281,201	$5,498	$2,577,572
Steven M. Pieper	Chief Financial Officer	$479,583	—	$1,107,000	—	$261,133	$6,301	$1,854,017
Ken Johnson	Senior Vice President, Global Development and Medical Affairs	$414,102	—	$430,500	—	$182,205	$31,622	$1,058,429

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul R. Edick	Chief Executive Officer	$693,934	—	$930,000	—	$499,632	$13,200	$2,136,766
Paul Edick	Former Chief Executive Officer	$693,934	—	$930,000	—	$499,632	$13,200	$2,136,766
John Shannon	Chief Executive Officer	$571,411	—	$930,000	—	$343,949	$2,793	$1,848,153
Steven M. Pieper	Chief Financial Officer	$435,985	—	$930,000	—	$231,957	$13,200	$1,611,142
Beth P. Hecht	Chief Legal Officer and Corporate Secretary	$460,601	—	$434,000	—	$221,800	$13,042	$1,129,443
Ken Johnson	Senior Vice President, Global Development and Medical Affairs	$398,174	—	$124,000	—	$191,738	$7,055	$720,967

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul R. Edick	Chief Executive Officer	$691,710	—	$1,686,000	—	$416,360	$11,529	$2,805,599
Paul Edick	Former Chief Executive Officer	$691,710	—	$1,686,000	—	$416,360	$11,529	$2,805,599
John Shannon	Chief Executive Officer	$549,433	—	$702,500	—	$275,600	$2,685	$1,530,218
Beth Hecht	Chief Legal Officer and Corporate Secretary	$442,214	—	$632,250	—	$177,724	$18,373	$1,270,561
Beth P. Hecht	Chief Legal Officer and Corporate Secretary	$442,214	—	$632,250	—	$177,724	$18,373	$1,270,561

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul R. Edick	Chief Executive Officer	$664,096	—	$1,143,000	$1,352,720	$598,518	$5,800	$3,764,134
Paul Edick	Chief Executive Officer	$664,096	—	$1,143,000	$1,352,720	$598,518	$5,800	$3,764,134
Barry Deutsch	Former Chief Financial Officer	$318,847	—	$584,200	—	$169,158	$726,915	$1,799,120
John Shannon	President and Chief Operating Officer	$527,500	—	$762,000	—	$396,175	$42,965	$1,728,640
Beth Hecht	Chief Legal Officer and Corporate Secretary	$417,183	—	$762,000	—	$239,760	$6,051	$1,424,994
Beth P. Hecht	Chief Legal Officer and Corporate Secretary	$417,183	—	$762,000	—	$239,760	$6,051	$1,424,994

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Edick	Chief Executive Officer	$626,977	—	$1,178,450	—	$453,222	$5,700	$2,264,349
John Shannon	President and Chief Operating Officer	$473,658	—	$414,050	$246,300	$300,000	$2,420	$1,436,428
Beth Hecht	Chief Legal Officer and Corporate Secretary	$392,852	—	$286,650	$369,450	$189,808	$5,634	$1,244,394

Key facts CIK 1867096 CUSIP 98422E103 13F (30d) 198 filings 197 filers Visit website Investor relations